We use artificial intelligence (AI) technology to explain the physical and chemical nature of biological systems.
What is our philosophy?
We aim to create and work from a data-driven foundation. We use a hybrid approach – computational drug design followed by wet lab validation – to greatly reduce the time and cost necessary for traditional drug discovery efforts.
Accutar Biotechnology Announces First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)